Form 4: CERO Director Rolfe Lindsey Granted Stock Options

CERO Therapeutics Holdings Director Rolfe Lindsey was granted 690,900 stock options exercisable at $0.055 per share.

Summary

• Rolfe Lindsey, a Director of CERO THERAPEUTICS HOLDINGS, INC. (CERO), was granted 690,900 stock options.
• The transaction occurred on January 7, 2026.
• Each option has an exercise price of $0.055.
• The options become exercisable on January 7, 2026, and are set to expire on January 6, 2036.
• Following this transaction, Rolfe Lindsey directly beneficially owns 690,900 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a standard compensation practice that aligns the director's interests with shareholders. It is not a significant event for the company's overall financial health but is a positive for corporate governance and incentive structure, indicating a neutral to slightly positive sentiment.

Positives

• The grant of stock options to Director Rolfe Lindsey aligns management's interests with those of shareholders, as the options gain value if the company's stock price increases above the exercise price.
• The options have a long expiration date of January 6, 2036, providing a significant window for potential value creation.

Risks

• The value of the stock options is contingent on the future performance of CERO's common stock, meaning they could expire worthless if the stock price does not exceed the exercise price of $0.055.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is solely focused on an insider's beneficial ownership change.

Industry Context

This insider transaction is a routine compensation event for a director and does not provide specific insights into broader industry trends or competitive landscape. It reflects standard practices for incentivizing corporate leadership through equity grants.

Stakeholder Impact

• Shareholders: Potentially positive due to increased alignment of the director's interests with shareholder value creation.
• Director (Rolfe Lindsey): Receives a significant equity incentive, linking personal financial success to the company's stock performance.

Key Dates

Keywords

CERO, stock options, insider transaction, Form 4, beneficial ownership, director compensation, equity incentive